Dr. David Morris Perlman, MD

Dr. Perlman practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Perlman's NPI, 1467536615, was assigned on October 24, 2006. Dr. Perlman graduated from University of Minnesota Medical School in 1996. Dr. Perlman holds Minnesota license 40592.

Dr. Perlman's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Perlman's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Perlman is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Perlman to 3 more hospitals, 9 medical groups, 5 group practices and clinics, 1 dialysis center and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perlman practices, 12 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Perlman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Perlman is licensed in Minnesota.

CMS data shows 264 Medicare services from Dr. Perlman across 10 procedure codes in 2024, for 178 Medicare patients. Medicare paid $20,273 for them.

CMS counts 178 Medicare patients who saw Dr. Perlman in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perlman's median patient age at 68, with 51% women.

In 2024, Dr. Perlman wrote 1,304 Medicare Part D claims for 174 patients. 65% of them were for generic drugs. CMS names the drug for 1,134 of them, across 25 drugs with 11 or more claims each, at $1,856,388 in total drug cost. In 2023, CMS named 1,056 claims across 25 drugs.

Dr. Perlman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Perlman as offering telehealth.

Dmand AI links 26 papers to Dr. Perlman, published from 2013 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Sarcoidosis, Phenotype and Lung. Dr. Perlman has published most often in Circ Arrhythm Electrophysiol. Dr. Perlman's most frequent co-authors are Maneesh Bhargava, MBBS, Jeremy Scott Markowitz, MD and Henri Roukoz, MD.

CMS Open Payments shows 3 general payments to Dr. Perlman from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $125.

Dr. Perlman graduated from University of Minnesota Medical School in 1996.